USP9X trims STAT1 to curb oncostatin M activity and intestinal inflammation
Ahmed N. Hegazy · 2026
Read USP9X trims STAT1 to curb oncostatin M activity and intestinal inflammation by Ahmed N. Hegazy (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13315572.txt.
Description
Ahmed N. Hegazy comments in 2026 on new work that finds a brake on a key gut inflammation signal in inflammatory bowel disease. In this disease, macrophages gather in the gut lining and keep making cytokines that damage tissue, and oncostatin M is one signal that also predicts failure of anti-TNF therapy.
The study under discussion shows the enzyme USP9X trims a specific ubiquitin tag from STAT1, which limits STAT1 entry to the nucleus and lowers oncostatin M output. Losing that brake in myeloid cells worsened lab colitis, and blocking oncostatin M reversed the harm. The pathway may offer a fresh treatment target.
Catalog record
| CREATOR | Ahmed N. Hegazy |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 8044 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |